Neuromuscular diseases are a group of conditions that affect the muscles and nerves controlling them. These diseases can cause muscle weakness, paralysis, pain, impaired tendon reflexes, increased sensitivity to touch, and other muscle and nerve impairments. Common neuromuscular diseases include myasthenia gravis, muscular dystrophy, amyotrophic lateral sclerosis (ALS), and peripheral neuropathy. Myasthenia gravis is an autoimmune disease that affects the neuromuscular junction controlling muscle contraction. In this disease, the immune system fails to recognize the body's muscles, leading to muscle weakness. Muscular dystrophy is a genetic disorder that causes gradual weakening of the muscles. This is caused by defects or damage in the genes that control muscle development. ALS is a progressive motor neuron disease caused by degeneration of the nerve cells responsible for muscle control. In ALS, cells in the brain and spinal cord that control muscle movement start to die, leading to muscles wasting away. Peripheral neuropathy is a disorder that affects the peripheral nerves which are responsible for sending messages between the brain and other parts of the body. Symptoms can include weakness and numbness of the affected areas and can lead to difficulties in walking or coordinating movement. To diagnose neuromuscular diseases, medical professionals may conduct a physical examination and run a series of tests. These tests can include a nerve conduction study, electromyography (EMG), and muscle biopsies. Treatment for neuromuscular diseases is individualized based on the patient's symptoms and the severity of the condition.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States